Skip to main content

Esther García Pagès

Institutions of which they are part

Postdoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Esther García Pagès

Institutions of which they are part

Postdoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

ERDERA: European Rare Disease Research Alliance

IP: M Mar Mañu Pereira
Collaborators: Sara Isabel Reidel , Sara Isabel Reidel , Miguel Chillon Rodriguez, Esther García Pagès, Raquel Mosull del Campo, Raquel Mosull del Campo, Simon Schwartz Navarro, Agustín Arasanz Duque, Agustín Arasanz Duque, Sandra Mancilla Zamora, Anna Collado Gimbert, Marc Miquel Moltó Abad, Ángela Menárguez López, Ángela Menárguez López, Ángela Menárguez López, Claire Diot
Funding agency: EUROPEAN COMMISSION
Funding: 771525
Reference: ERDERA_MAÑU_EC_HLTH2023-DISEASE-07-01/2023
Duration: 01/09/2024 - 31/08/2031

HemaFAIR: Fostering F.A.I.R. Data and Standards in Rare Hematological Diseases

IP: M Mar Mañu Pereira
Collaborators: Sara Isabel Reidel , Núria Torquet i Luna, Esther García Pagès
Funding agency: EUROPEAN COMMISSION
Funding: 221875
Reference: HEMAFAIR/EC/WIDERA-2023-ACCESS-02-01/2023/MAÑU
Duration: 01/06/2024 - 30/06/2027

IMPACT- AML

IP: M Mar Mañu Pereira
Collaborators: Sara Isabel Reidel , Núria Torquet i Luna, Núria Torquet i Luna, Esther García Pagès, Esther García Pagès, Ángela Menárguez López, Ángela Menárguez López, Clara Durlach, Clara Durlach, Daiana Natali Lopez
Funding agency: EUROPEAN COMMISSION
Funding: 244375
Reference: IMPACT-AML_M.MAÑU_HE_2022
Duration: 01/04/2023 - 31/03/2028

GENOMED4ALL - Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases

IP: M Mar Mañu Pereira
Collaborators: Sara Isabel Reidel , Esther García Pagès, Anna Collado Gimbert, Ángela Menárguez López, Amira Idrizovic
Funding agency: EUROPEAN COMMISSION
Funding: 434000
Reference: GENOMED4ALL_H2020-SC1-FA-DTS-2018-20_2020
Duration: 01/01/2021 - 30/06/2025

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Vall d'Hebron is one of the centers that coordinate this network, which so far has enabled the detection of high-risk genetic alterations and the provision of personalized treatments that have already achieved remission in cases with very few therapeutic alternatives.

The projects, selected under the 2026 Health Research and CaixaImpulse Health Innovation calls, address topics ranging from new therapies for childhood neurological disorders and Parkinson’s disease to the treatment of mitochondrial diseases and cancer.

Related professionals

Aitor Uribarri Gonzalez

Aitor Uribarri Gonzalez

Senior researcher
Cardiovascular Diseases
Read more
Herimar Meneses Fuenmayor

Herimar Meneses Fuenmayor

Gestió i Administració
Quality, Processes and Document Management Unit
Digital Transformation Directorate
Read more
Maria Cristina Caparros Felipe

Maria Cristina Caparros Felipe

Research technician
Transfusional Medicine
Read more
Maria Cecilia Juárez Dobjanschi

Maria Cecilia Juárez Dobjanschi

Predoctoral researcher
Systemic Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.